Real-World Evidence

Powering life sciences with real-world data

Navigate the complexities of Real-World Evidence analysis with confidence.

The Challenge of Using Real-World Evidence

Life sciences companies strive to make Real-World Evidence (RWE) a routine part of decision-making but often face challenges in optimizing their use of real-world data (RWD).

Early commercial assessments must balance limited resources with the need for optimal analyses, as teams may lack ownership of relevant data or the budget for custom analytical projects.

Patient finding is the foundation of market sizing and forecasting—a core driver in understanding opportunity within a disease space. For leaders focused on diseases with small patient populations, patient finding plays a vital role throughout the product lifecycle. Measuring unmet needs in the marketplace paves the way for successful product launches. Demonstrating the measurable value of an asset with clear differentiation supports both market access and reimbursement strategy.

Clinical teams need to identify patients for trial recruitment and site selection, commercial teams must find diagnosed and undiagnosed patients for planning, targeting, and alerting.

Consistent, Actionable Real-World Insights

Trinity Real-World Evidence provides meaningful solutions by partnering closely with life sciences leaders. We deliver context-specific, fit-for-purpose insights and leverage the right data assets, ranging from an organization’s existing resources to Trinity’s unique in-house data portfolio.

Market & Therapy Area Landscape Assessment

How can New Product Planning leaders quickly size patient populations and define the disease and market landscape to make timely business development decisions?

Evidence-Based Value Arguments

How can HEOR leaders use RWE to strengthen evidence planning, evidence generation, and scientific dissemination while answering key questions on patients, burden of illness, and therapy/treatment landscapes?

Patient/Treatment Flow

How can pre-launch teams leverage RWE-driven patient flows to build objective views of the patient journey that support brand and launch planning?

Brand Health Assessment

How can in-market brands apply RWE to assess performance and identify the key levers that influence outcomes in real-world market contexts?

Our Impact

Designed by Domain Experts: Drive high-impact RWE insights based on analytics and methodologies to navigate brand and market complexity with precision.
Flexible Data Access: Use the most relevant data assets tailored to each question, therapy area, and brand challenge.
Long-term Thought Partnership: Equip teams with insights that guide strategy across the entire asset lifecycle.
Bespoke AIML & Analytics: Enhance RWE solutions with advanced methodologies aligned to each organization’s business goals and data needs.

Expertise in Applying RWE and Technology

Trinity Real-World Evidence combines tech-enabled capabilities, proven methodologies, and nearly 30 years of life sciences expertise to accelerate time to insight and deliver the depth of analytics required for nuanced studies.

Our dedicated RWE team works with your existing data resources and integrates them seamlessly with Trinity’s extensive network of direct data access data partnerships.